Prolacta Bioscience, the leader in human milk nutrition for premature
infants in the neonatal intensive care unit (NICU), today announced that
they have made an additional shipment of pasteurized human milk for the
International Breast Milk Project (IBMP). The donated services include
conducting the qualification of milk donors as well as the safety and quality
testing of the donor milk and pasteurization.
The breast milk is sent to milk banks in South Africa for infants
suffering from malnourishment, hunger and life-threatening illnesses.
This shipment of donor breast milk is to be utilized by premature, sick
and orphaned infants in South Africa. The Cape Town and Durban based
non-profits, Milk Matters and iThemba Lethu, distribute donor breast
milk to over 25 major hospitals and two orphan homes for children
affected by AIDS, helping save the lives of premature, and sick babies.
"I have an abiding sense of relief whenever we are able to give a
preterm baby breast milk," said Mark Richards, pediatrician at New
Somerset Hospital in Cape Town, South Africa. "To have recourse to a
donated milk resource is no less than a lifesaving service. Thank you to
International Breast Milk Project for your life saving support."
The breast milk processed for shipment was donated through the
International Breast Milk Project Milk Bank, which is operated by
Prolacta Bioscience. The donor milk program allows mothers to donate
from the comfort of their homes, and the family doesn't incur any
out-of-pocket expenses. The initial screening is done online, certified
phlebotomists come to the mother's home, and all of the storage and
shipping supplies are sent directly to the mom. Shipment pick-up is then
arranged so that mother and baby won't be burdened by having to drive
the shipment coolers anywhere. Quick International Courier, a global
priority transportation organization, will be donating the shipping
services and logistics planning from the U.S. to South Africa.
Under a five-year agreement, which began November 1, 2010, Prolacta
donates the processing of donor human breast milk to be shipped to
Africa for infants in need. The agreement between Prolacta and IBMP is
for donated milk up to 600,000 ounces annually. Within each year, when
100,000 to 400,000 ounces of donor milk is collected by the IBMP Milk
Bank, 25% of that milk will be processed for shipment to Africa. The
remaining 75% will remain in the United States and will be used by
Prolacta to make a Human Milk Fortifier (HMF) for critically ill and
premature infants in the neonatal intensive care unit (NICU). This HMF
is the only available HMF made from human breast milk, as opposed to cow
milk. For every ounce of milk that remains in the U.S., Prolacta pays
IBMP one dollar. The breast milk donations are made through the IBMP
Milk Bank, which is operated by Prolacta Bioscience. To date, Prolacta
has donated nearly $650,000 to IBMP. More information can be found at http://breastmilkproject.org.
Prolacta is setting the new standard of safety and quality in human milk
processing, with a pharmaceutical grade manufacturing facility that is
the first and only of its kind worldwide. Additionally, Prolacta is the
only organization that includes a safety combination of DNA matching of
mom to milk, testing for drugs and other contamination, as well as
HIV-1, HCV, and HBV through PCR testing to ensure the highest-quality
available human milk products to feed the sickest infants in hospital
NICUs. Prolacta's advanced technology provides for an unmatched margin
of safety to protect from potential transmission of virus. Please
join in on the conversation about Prolacta.
About Prolacta Bioscience
Prolacta Bioscience, Inc., www.prolacta.com,
is a life science company dedicated to improving quality of life by
Advancing the Science of Human Milk®. Prolacta creates
specialty formulations made exclusively from human milk for the
nutritional needs of critically ill, premature infants in NICU. It is
the first and only company to provide a commercially available human
milk fortifier made from 100% human milk, Prolact+ H2MF.
Prolacta operates a pharmaceutical grade processing plant and have
designed and patented processes that enable them to make their
one-of-a-kind products. Prolacta is committed to making a meaningful
difference in the lives of the most vulnerable premature babies through
world-class research and innovative products.
International Breast Milk Project is the only
organization in the world to provide large provisions of donor breast
milk to infants suffering from HIV/AIDS, malnourishment, poverty and
disease in Africa. As of this year, IBMP has provided over 300,000
ounces, or 79,000 bottles, of life-giving donor breast milk to infants
in South Africa.
Loren Kosmont, 310-721-9444